Exosomes are nanosized extracellular vesicles (EVs) that show great promise in tissue
regeneration and injury repair as mesenchymal stem cell (MSC). MSC has been shown to …

Background Mesenchymal stem cell (MSC)-based therapy is currently considered to be an
effective treatment strategy for diabetes and hepatic disorders, such as liver cirrhosis and …

Diabetes mellitus (DM) is a metabolic disease, now prevalent worldwide, which is
characterized by a relative or absolute lack of insulin secretion leading to chronically …

Stem cell-derived exosomes have exhibited promise for applications in tissue regeneration.
However, one major problem for stem cell-derived exosome therapies is identifying …

Background Mesenchymal stem cell (MSC)-derived exosomes emerge as promising
candidates for treating delayed wound healing in diabetes due to the promotion of …

Aims/hypothesis Diabetic peripheral neuropathy (DPN) is one of the major complications of
diabetes, which contributes greatly to morbidity and mortality. There is currently no effective …

Diabetic wounds remain a great challenge for clinicians due to the multiple bacterial
infections and oxidative damage. Exosomes, as an appealing nanodrug delivery system …

Some scholars have suggested that the clinical application of exosomes derived from
human umbilical cord mesenchymal stem cells (hucMSCs-exo) might represent a novel …

Type 1 diabetes, has been recognized as an autoimmune disease. Like other
immunological conditions, regulation of immune response is a key strategy to control the …

Background Mesenchymal stem cell (MSC)-derived exosomes have seen great advances in
human disease control in a minimally invasive manner. This research aimed to explore the …